Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B.
about
Bortezomib induced hepatitis B reactivation.Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders.Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era.Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy.Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.
P2860
Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Bortezomib monotherapy in pati ...... h reactivation of hepatitis B.
@en
Bortezomib monotherapy in pati ...... h reactivation of hepatitis B.
@nl
type
label
Bortezomib monotherapy in pati ...... h reactivation of hepatitis B.
@en
Bortezomib monotherapy in pati ...... h reactivation of hepatitis B.
@nl
prefLabel
Bortezomib monotherapy in pati ...... h reactivation of hepatitis B.
@en
Bortezomib monotherapy in pati ...... h reactivation of hepatitis B.
@nl
P2093
P2860
P356
P1476
Bortezomib monotherapy in pati ...... h reactivation of hepatitis B.
@en
P2093
P2860
P304
P356
10.1111/IMJ.12180
P577
2013-07-01T00:00:00Z